Schematic representation of the Gavo-cel study design.
Tumor
TUMOR
Tumor biopsies were evaluated for mesothelin (MSLN) expression at enrolment, followed by leukapheresis and gavo-cel manufacture. The enrolled patients underwent lymphodepletion with fludarabine at 30 mg/m
